$BLNC
Balance Labs, Inc. Stock $blnc

$blnc Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222023933 Filed on August 24, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue	$67.50K	$67.50K	$424.6K
YoY Change	-66.25%		-57.54%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$24.85K	$79.03K	$109.4K
YoY Change	-75.11%	-17.36%	21.88%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
% of Gross Profit
Operating Expenses	$24.85K	$79.03K	$109.4K
YoY Change	-75.1%	-17.36%	21.88%
Operating Profit	$42.65K	-$11.53K
YoY Change	-57.43%	-87.94%
Interest Expense	$57.51K	$58.62K	-$3.877M
YoY Change	-98.19%	4.75%	7022.43%
% of Operating Profit	134.85%
Other Income/Expense, Net	-$185.2K	-$195.9K
YoY Change	-106.13%	118.74%
Pretax Income	-$142.6K	-$207.4K	-$3.562M
YoY Change	-104.57%	12.01%	-516.16%
Income Tax
% Of Pretax Income
Net Earnings	-$142.6K	-$207.4K	-$3.562M
YoY Change	-104.56%	13.68%	-515.29%
Net Earnings / Revenue	-211.23%	-307.3%	-838.82%
Basic Earnings Per Share	$0.00	-$0.01
Diluted Earnings Per Share	$0.00	-$9.570K	-$164.3K
COMMON SHARES
Basic Shares Outstanding	21.67M shares	21.67M shares
Diluted Shares Outstanding	21.67M shares	21.67M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$515.3K	$546.6K	$777.6K
YoY Change	131.77%	398.85%	13711.99%
Cash & Equivalents	$269.7K	$227.8K	$227.6K
Short-Term Investments	$245.5K	$318.9K	$550.1K
Other Short-Term Assets			$0.00
YoY Change			-100.0%
Inventory
Prepaid Expenses
Receivables	$22.50K	$45.00K	$22.50K
Other Receivables	$21.96K	$159.4K	$175.6K
Total Short-Term Assets	$314.2K	$432.2K	$425.7K
YoY Change	-12.84%	107.47%	1289.76%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles			$0.00
YoY Change
Long-Term Investments			$18.81K
YoY Change
Other Assets	$245.5K	$338.9K	$588.9K
YoY Change
Total Long-Term Assets	$245.5K	$338.9K	$588.9K
YoY Change	-94.07%	-73.04%	-52.5%
TOTAL ASSETS
Total Short-Term Assets	$314.2K	$432.2K	$425.7K
Total Long-Term Assets	$245.5K	$338.9K	$588.9K
Total Assets	$559.7K	$771.0K	$1.015M
YoY Change	-87.57%	-47.38%	-20.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$911.7K	$911.7K	$851.7K
YoY Change	10.95%	15.16%	16.4%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.699M	$1.699M	$1.699M
YoY Change	1.49%	-5.91%	19.19%
Long-Term Debt Due	$280.0K	$280.0K	$276.6K
YoY Change	1.89%	2.55%	21.94%
Total Short-Term Liabilities	$4.047M	$4.119M	$3.939M
YoY Change	4.59%	4.17%	16.27%
LONG-TERM LIABILITIES
Long-Term Debt	$477.3K	$474.5K	$468.8K
YoY Change	2.43%	2.45%	-0.28%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$477.3K	$474.5K	$468.8K
YoY Change	2.43%	2.45%	-0.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.047M	$4.119M	$3.939M
Total Long-Term Liabilities	$477.3K	$474.5K	$468.8K
Total Liabilities	$4.525M	$4.593M	$4.408M
YoY Change	5.99%	5.38%	15.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.777M	-$4.635M	-$4.205M
YoY Change
Common Stock	$2.167K	$2.167K	$2.167K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.965M	-$3.822M	-$3.393M
YoY Change
Total Liabilities & Shareholders Equity	$559.7K	$771.0K	$1.015M
YoY Change	-87.57%	-47.38%	-20.14%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	-$142.6K	-$207.4K	-$3.562M
YoY Change	-104.56%	13.68%	-515.29%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Operating Activities	$51.00K	$13.87K	-$2.910K
YoY Change	-61.09%	-124.1%	-93.42%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$9.030K	$0.00	-$16.86K
YoY Change	-84.52%
Cash From Investing Activities	-$9.030K	$0.00	-$16.86K
YoY Change	-84.52%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	25.00K
YoY Change	-100.0%	-100.0%	-43.82%
NET CHANGE
Cash From Operating Activities	51.00K	13.87K	-2.910K
Cash From Investing Activities	-9.030K	0.000	-16.86K
Cash From Financing Activities	0.000	0.000	25.00K
Net Change In Cash	41.97K	13.87K	5.230K
YoY Change	-62.77%	-86.39%	1911.54%
FREE CASH FLOW
Cash From Operating Activities	$51.00K	$13.87K	-$2.910K
Capital Expenditures		$0.00	$0.00
Free Cash Flow		$13.87K	-$2.910K
YoY Change		-128.86%	-93.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Depreciation Depreciation		usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	BLNC	Equity Method Investment Summarized Financial Information Income EquityMethodInvestmentSummarizedFinancialInformationIncome		usd
	BLNC	Equity Method Investment Summarized Financial Information Income EquityMethodInvestmentSummarizedFinancialInformationIncome		usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments		usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001632121
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q2	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments		usd
CY2021Q2	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments		usd
	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments		usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Depreciation Depreciation		usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	BLNC	Proceeds From Issuance Of Convertible Note Payable Related Party Net ProceedsFromIssuanceOfConvertibleNotePayableRelatedPartyNet		usd
	BLNC	Proceeds From Short Term Advances Related Parties ProceedsFromShortTermAdvancesRelatedParties		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	BLNC	Investment At Fair Value Received From Issuance Of Note Receivable InvestmentAtFairValueReceivedFromIssuanceOfNoteReceivable		usd
	BLNC	Beneficial Conversion Features On Convertible Notes Payable Related Party BeneficialConversionFeaturesOnConvertibleNotesPayableRelatedParty		usd
	BLNC	Notes Receivableand Interest Receivable Convertedto Shares NotesReceivableandInterestReceivableConvertedtoShares		usd
CY2022Q2	BLNC	Equity In Joint Venture EquityInJointVenture		usd
CY2021Q4	BLNC	Equity In Joint Venture EquityInJointVenture		usd
CY2022Q2	BLNC	Equity Method Investment Summarized Financial Information Assets1 EquityMethodInvestmentSummarizedFinancialInformationAssets1		usd
CY2021Q4	BLNC	Equity Method Investment Summarized Financial Information Assets1 EquityMethodInvestmentSummarizedFinancialInformationAssets1		usd
CY2022Q2	us-gaap	Depreciation Depreciation		usd
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-202959
	dei	Entity Registrant Name EntityRegistrantName	BALANCE LABS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1146785
	dei	Entity Address Address Line1 EntityAddressAddressLine1	407 Lincoln Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 701
	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33139
	dei	City Area Code CityAreaCode	(305)
	dei	Local Phone Number LocalPhoneNumber	907-7600
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21674000	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	227769	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	227558	usd
CY2022Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	45000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	22500	usd
CY2022Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	18404	usd
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	12932	usd
CY2022Q2	BLNC	Notes Receivable Unamortized Discount Current NotesReceivableUnamortizedDiscountCurrent	0	usd
CY2021Q4	BLNC	Notes Receivable Unamortized Discount Current NotesReceivableUnamortizedDiscountCurrent	3308	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	141000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	162692	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	432173	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	425682	usd
CY2022Q2	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	20000	usd
CY2021Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	20000	usd
CY2022Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	318874	usd
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	550057	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	18812	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	338874	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	588869	usd
CY2022Q2	us-gaap	Assets Assets	771047	usd
CY2021Q4	us-gaap	Assets Assets	1014551	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1125589	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1010028	usd
CY2022Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	911659	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	851659	usd
CY2022Q2	BLNC	Due To Related Parties Current Exclude Notes Payable Related Parties Classified DueToRelatedPartiesCurrentExcludeNotesPayableRelatedPartiesClassified	1673558	usd
CY2021Q4	BLNC	Due To Related Parties Current Exclude Notes Payable Related Parties Classified DueToRelatedPartiesCurrentExcludeNotesPayableRelatedPartiesClassified	1673558	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	25000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	25000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	3428	usd
CY2022Q2	BLNC	Due To Related Party Current DueToRelatedPartyCurrent	173192	usd
CY2021Q4	BLNC	Due To Related Party Current DueToRelatedPartyCurrent	169764	usd
CY2022Q2	BLNC	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	0	usd
CY2021Q4	BLNC	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	0	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	106850	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	106850	usd
CY2022Q2	BLNC	Accumulated Losses Of Unconsolidated Investees In Excess Of Investment AccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment	103064	usd
CY2021Q4	BLNC	Accumulated Losses Of Unconsolidated Investees In Excess Of Investment AccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment	101838	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4118912	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3938697	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	25515	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	31185	usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	474485	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	468815	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	474485	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	468815	usd
CY2022Q2	us-gaap	Liabilities Liabilities	4593397	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4407512	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21674000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21674000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21674000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21674000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2167	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2167	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	810048	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	810048	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4634565	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4205176	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3822350	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3392961	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	771047	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1014551	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67500	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	135000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7256	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11908	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11295	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17808	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	31248	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	15620	usd
	us-gaap	Professional Fees ProfessionalFees	75460	usd
	us-gaap	Professional Fees ProfessionalFees	40650	usd
CY2022Q2	us-gaap	Salaries And Wages SalariesAndWages	10529	usd
CY2021Q2	us-gaap	Salaries And Wages SalariesAndWages	38105	usd
	us-gaap	Salaries And Wages SalariesAndWages	33821	usd
	us-gaap	Salaries And Wages SalariesAndWages	72496	usd
CY2022Q2	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	30000	usd
CY2021Q2	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	30000	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	60000	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	60000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	79033	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	95633	usd
	us-gaap	Operating Expenses OperatingExpenses	180576	usd
	us-gaap	Operating Expenses OperatingExpenses	190954	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11533	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-95633	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-45576	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-190954	usd
CY2022Q2	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	-99649	usd
CY2021Q2	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	-15000	usd
	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	-231184	usd
	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	-20500	usd
	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	287	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-41102	usd
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-32142	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-47256	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-53148	usd
CY2022Q2	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	3473	usd
CY2021Q2	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	13545	usd
	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	10997	usd
	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	22740	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	58616	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	55960	usd
	us-gaap	Interest Expense InterestExpense	116657	usd
	us-gaap	Interest Expense InterestExpense	126501	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-195894	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-89557	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-383813	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-177409	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-207427	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-185190	usd
	us-gaap	Profit Loss ProfitLoss	-429389	usd
	us-gaap	Profit Loss ProfitLoss	-368363	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2729	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4504	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-207427	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-182461	usd
	us-gaap	Net Income Loss NetIncomeLoss	-429389	usd
	us-gaap	Net Income Loss NetIncomeLoss	-363859	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3614923	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-207427	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3822350	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3392961	usd
	us-gaap	Profit Loss ProfitLoss	-429389	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3822350	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2770529	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3799	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-185190	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2951920	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2587356	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3799	usd
	us-gaap	Profit Loss ProfitLoss	-368363	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2951920	usd
	us-gaap	Profit Loss ProfitLoss	-429389	usd
	us-gaap	Profit Loss ProfitLoss	-368363	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9098	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5688	usd
	BLNC	Accreted Interest Income On Note Receivable AccretedInterestIncomeOnNoteReceivable	3308	usd
	BLNC	Accreted Interest Income On Note Receivable AccretedInterestIncomeOnNoteReceivable	17809	usd
	us-gaap	Depreciation Depreciation	80	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1336	usd
	BLNC	Equity Method Investment Summarized Financial Information Net Loss EquityMethodInvestmentSummarizedFinancialInformationNetLoss	46030	usd
	BLNC	Equity Method Investment Summarized Financial Information Net Loss EquityMethodInvestmentSummarizedFinancialInformationNetLoss	13406	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-231183	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-20500	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	22500	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	7690	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	4923	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-25000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	115561	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	40290	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	60000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	60000	usd
	BLNC	Increase Decrease In Accumulated Income Losses Of Unconsolidated Investees In Excess Of Investment IncreaseDecreaseInAccumulatedIncomeLossesOfUnconsolidatedInvesteesInExcessOfInvestment	-1226	usd
	BLNC	Increase Decrease In Accumulated Income Losses Of Unconsolidated Investees In Excess Of Investment IncreaseDecreaseInAccumulatedIncomeLossesOfUnconsolidatedInvesteesInExcessOfInvestment	-39742	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	211	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-185053	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	119000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-128500	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	25000	usd
	BLNC	Proceeds From Issuance Of Convertible Note Payable Related Party Net ProceedsFromIssuanceOfConvertibleNotePayableRelatedPartyNet	50000	usd
	BLNC	Proceeds From Short Term Advances Related Parties ProceedsFromShortTermAdvancesRelatedParties	392500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	417500	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	211	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	103947	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	227558	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5632	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	227769	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	109579	usd
	us-gaap	Interest Paid Net InterestPaidNet	27545	usd
	BLNC	Investment At Fair Value Received From Issuance Of Note Receivable InvestmentAtFairValueReceivedFromIssuanceOfNoteReceivable	43000	usd
	BLNC	Beneficial Conversion Features On Convertible Notes Payable Related Party BeneficialConversionFeaturesOnConvertibleNotesPayableRelatedParty	3799	usd
	BLNC	Notes Receivableand Interest Receivable Convertedto Shares NotesReceivableandInterestReceivableConvertedtoShares	27218	usd
CY2022Q2	BLNC	Notes Receivable NotesReceivable	25000	usd
CY2022Q2	us-gaap	Interest Receivable InterestReceivable	2218	usd
CY2022Q2	BLNC	Unrealized Loss On Investments UnrealizedLossOnInvestments	27218	usd
	BLNC	Unrealized Loss On Investments UnrealizedLossOnInvestments	27218	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	211	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	227769	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4634565	usd
CY2022Q2	BLNC	Working Capital Deficit WorkingCapitalDeficit	3686739	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zAaXgwI42Eq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zm5EbFErBKj8">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to stock-based compensation, depreciable lives of fixed assets and deferred tax assets. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021	BLNC	Impairment Of Investment ImpairmentOfInvestment	195000	usd
CY2020Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1000000	shares
CY2022Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	318874	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.80
CY2022Q2	BLNC	Equity Method Investment Summarized Financial Information Liabilities1 EquityMethodInvestmentSummarizedFinancialInformationLiabilities1	242513	usd
CY2021Q4	BLNC	Equity Method Investment Summarized Financial Information Liabilities1 EquityMethodInvestmentSummarizedFinancialInformationLiabilities1	239671	usd
CY2022Q2	BLNC	Equity Method Investment Summarized Financial Information Equity1 EquityMethodInvestmentSummarizedFinancialInformationEquity1	-242513	usd
CY2021Q4	BLNC	Equity Method Investment Summarized Financial Information Equity1 EquityMethodInvestmentSummarizedFinancialInformationEquity1	-239671	usd
	BLNC	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	2842	usd
	BLNC	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	92102	usd
	BLNC	Equity Method Investment Summarized Financials Information Net Income Loss EquityMethodInvestmentSummarizedFinancialsInformationNetIncomeLoss	-2842	usd
	BLNC	Equity Method Investment Summarized Financials Information Net Income Loss EquityMethodInvestmentSummarizedFinancialsInformationNetIncomeLoss	-92102	usd
	BLNC	Equity Method Investment Percentage Description EquityMethodInvestmentPercentageDescription	When the fair value of an investment is indeterminable, the Company accounts for its investments that are under 20% of the total equity outstanding using the cost method. For investments in which the Company holds between 20-50% equity and is non-controlling are accounted for using the equity method. For any investments in which the Company holds over 50% of the outstanding stock, the Company consolidates those entities into their consolidated financial statements herein
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zKI4r7DxBR18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_861_zo0cv2Yy87Lh">Concentration of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and marketable securities. As of June 30, 2022 and December 31, 2021, the carrying value of marketable securities was $<span id="xdx_907_eus-gaap--MarketableSecurities_iI_pp0p0_c20220630_zMUss9YZlct6" title="Marketable securities">318,874</span> and $<span id="xdx_90A_eus-gaap--MarketableSecurities_iI_pp0p0_c20211231_z4pQmW6vH8ia" title="Marketable securities">550,057</span>, respectively. The securities are included in the Investment at Fair Value – Related Party on the consolidated balance sheets, which consist of common shares held in one (1) investment which currently is trading on the Over-the-Counter Bulletin Board (OTCBB). On September 14, 2021, the S-1 Registration Statement for EZFill Holdings, Inc., a related party, was declared effective by Securities and Exchange Commission. As of June 30, 2022 and December 31, 2021, the Company has classified this as Level 1 asset on the fair value hierarchy because the investment is valued based on quoted market price using observable inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Marketable Securities MarketableSecurities	318874	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	550057	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	466	usd
CY2021Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1373	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	514	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3329	usd
	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	three to five years.
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11316	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11316	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11316	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11316	usd
CY2021Q2	us-gaap	Depreciation Depreciation	40	usd
	us-gaap	Depreciation Depreciation	80	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	0	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	9500	usd
CY2021Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1336	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1336	usd
CY2022Q2	BLNC	Retained Earnings RetainedEarnings	66650	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4205176	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3392961	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1014551	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	27218	usd
CY2022Q2	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	68045	shares
CY2022Q2	BLNC	Accreted Interest On Note Receivable AccretedInterestOnNoteReceivable	0	usd
	BLNC	Accreted Interest On Note Receivable AccretedInterestOnNoteReceivable	3308	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2022Q2	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	2967	usd
	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	5901	usd
CY2016Q3	us-gaap	Area Of Land AreaOfLand	2200	sqft
CY2017Q3	BLNC	Monthly Base Rent MonthlyBaseRent	7741	usd
CY2018	BLNC	Monthly Base Rent MonthlyBaseRent	7973	usd
CY2016Q3	BLNC	Percentage Of Additional Base Rent PercentageOfAdditionalBaseRent	0.50	pure
CY2016Q3	us-gaap	Lease Cost LeaseCost	16725	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67500	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	135000	usd
CY2022Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	45000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	22500	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd

Files In Submission

Name	View Source	Status
0001493152-22-023933-index-headers.html	Edgar Link	pending
0001493152-22-023933-index.html	Edgar Link	pending
0001493152-22-023933.txt	Edgar Link	pending
0001493152-22-023933-xbrl.zip	Edgar Link	pending
blnc-20220630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
blnc-20220630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
blnc-20220630_pre.xml	Edgar Link	unprocessable
blnc-20220630_cal.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
blnc-20220630_lab.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLNC
Balance Labs, Inc. Stock $blnc

2022 Q3 Form 10-Q Financial Statement

#000149315222023933 Filed on August 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLNC Balance Labs, Inc. Stock $blnc

2022 Q3 Form 10-Q Financial Statement

#000149315222023933 Filed on August 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLNC
Balance Labs, Inc. Stock $blnc